Table 1 The relation between EFNA1/2/3/4/5 expression and clinical characteristics in LUAD in TCGA
Characteristics | EFNA1 (P value) | EFNA2 (P value) | EFNA3 (P value) | EFNA4 (P value) | EFNA5 (P value) |
|---|---|---|---|---|---|
Pathologic stage (I, II, III, IV) | 0.476 | 0.348 | 0.642 | 0.940 | 0.251 |
Gender (Female, Male) | 1.000 | 0.575 | 0.894 | 0.364 | 0.514 |
Race (Asian, Black or African American, White) | 0.687 | 0.213 | 0.321 | 0.159 | 0.193 |
Age (≤ 65, > 65) | 0.186 | 0.114 | 0.216 | 0.008 | 0.292 |
Age, median (IQR) | 0.213 | 0.176 | 0.037 | 0.019 | 0.317 |
Residual tumor (R0, R1, R2) | 0.918 | 0.005 | 1.000 | 0.219 | 0.558 |
Anatomic neoplasm subdivision1 (Left, Right) | 1.000 | 0.061 | 0.196 | 1.000 | 0.427 |
Anatomic neoplasm subdivision2 (Central, Peripheral) | 0.909 | 0.833 | 0.765 | 0.466 | 0.675 |
Number pack years smoked (< 40, ≥ 40) Smoker (No, Yes) | 0.434 0.682 | 0.232 0.219 | 0.234 1.000 | 0.962 0.986 | 0.011 1.000 |